×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Aspira Pathlab & Diagnostics L | NA | NA | NA | NA | 64.8 | 25.3 |
| Jeevan Scientific Technology L | NA | NA | NA | NA | 63.4 | 1,268 |
| GODAVARI DRUGS LTD. | NA | NA | NA | NA | 62.4 | 16.5 |
Aspira Pathlab & Diagnostics Limited, with Security Code 540788, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.4 | 3.4 | 2.6 | 3.3 | 3.5 | 3.8 | 4.6 | 6.2 | 5.4 | 5.8 |
| Expenses | 3.6 | 3.3 | 2.9 | 3.7 | 3.8 | 3.9 | 4.3 | 4.8 | 4.6 | 4.6 |
| Operating Profit | 0.8 | 0.1 | -0.3 | -0.4 | -0.4 | -0.1 | 0.3 | 1.4 | 0.8 | 1.1 |
| OPM % | 18.7% | 4.17% | -12.52% | -11.08% | -10.75% | -3.09% | 7.53% | 21.98% | 14.2% | 19.68% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Profit before tax | 0.4 | -0.3 | -0.7 | -0.7 | -0.7 | -0.5 | 0.0 | 1.0 | 0.4 | 0.8 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.4 | -0.3 | -0.7 | -0.7 | -0.7 | -0.5 | 0.0 | 1.0 | 0.4 | 0.7 |
| EPS in Rs | 0.43 | -0.25 | -0.7 | -0.69 | -0.72 | -0.49 | -0.02 | 0.96 | 0.37 | 0 |
| Metrics | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 4.6 | 4.6 | 6.2 | 5.4 | 5.8 |
| Expenses | 4.3 | 4.3 | 4.8 | 4.6 | 4.6 |
| Operating Profit | 0.3 | 0.3 | 1.4 | 0.8 | 1.1 |
| OPM % | 7.53% | 7.53% | 21.98% | 14.2% | 19.68% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Profit before tax | 0.0 | 0.0 | 1.0 | 0.4 | 0.8 |
| Tax % | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.0 | 0.0 | 1.0 | 0.3 | 0.7 |
| EPS in Rs | 0.1 | 0.1 | 0.96 | 0.3 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 4% |
| TTM: | 67% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 20% |
| 3 Years: | -23% |
| TTM: | 178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 3% |
| 1 Year: | 89% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 67% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 176% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 3% |
| 1 Year: | 89% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|